Cargando…
The Value of Inflammatory Biomarkers in Differentiating Asthma–COPD Overlap from COPD
PURPOSE: To evaluate the accuracy of inflammatory biomarkers in differentiating patients with asthma–COPD overlap (ACO) from those with COPD alone. METHODS: Clinical data of 134 patients with COPD and 48 patients with ACO admitted to the First Affiliated Hospital of Xi’an Jiaotong University from Ja...
Autores principales: | Li, Meng, Yang, Tian, He, Ruiqing, Li, Anqi, Dang, Wenhui, Liu, Xinyu, Chen, Mingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685357/ https://www.ncbi.nlm.nih.gov/pubmed/33244228 http://dx.doi.org/10.2147/COPD.S273422 |
Ejemplares similares
-
Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap
por: Gao, Jie, et al.
Publicado: (2017) -
Inflammatory biomarkers in asthma-COPD overlap syndrome
por: Kobayashi, Seiichi, et al.
Publicado: (2016) -
Using inflammatory index to distinguish asthma, asthma-COPD overlap and COPD: A retrospective observational study
por: Ma, Haiman, et al.
Publicado: (2022) -
Importance of fractional exhaled nitric oxide in the differentiation of asthma–COPD overlap syndrome, asthma, and COPD
por: Chen, Feng-jia, et al.
Publicado: (2016) -
Biomarker-based detection of asthma–COPD overlap syndrome in COPD populations
por: Tamada, Tsutomu, et al.
Publicado: (2015)